PIM
RVMD icon

Platinum Investment Management’s Revolution Medicines RVMD Stock Holding History

Platinum Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Sell
16,994
-3,819
-18% -$558K 0.78% 50
2026
Q1 		$2.02M Buy
20,813
+2,161
+12% +$218K 0.51% 63
2025
Q4 		$1.49M Sell
18,652
-1,924
-9% -$126K 0.34% 75
2025
Q3 		$961K Buy
+20,576
New +$806K 0.06% 83

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Platinum Investment Management's RVMD Position: Q2 2026 in Review

Platinum Investment Management reduced its Revolution Medicines (RVMD) stake by 18% in Q2 2026, selling an estimated $558K and leaving 16,994 shares worth $3.18M. The position accounts for 0.78% of the portfolio, ranked #50.

Platinum Investment Management first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Platinum Investment Management held 16,994 shares of Revolution Medicines worth $3.18M as of Q2 2026.
  • Platinum Investment Management sold 3,819 Revolution Medicines shares in Q2 2026, an estimated $558K.
  • Revolution Medicines made up 0.78% of Platinum Investment Management's portfolio in Q2 2026, its #50 holding.
  • Platinum Investment Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Platinum Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.